No abstract available
Keywords:
Adjuvant treatment; Anti-PD1; Cancer urothélial; Immunotherapy; Immunothérapie; Traitement adjuvant; Urothelial carcinoma.
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
B7-H1 Antigen
-
Carcinoma, Transitional Cell* / drug therapy
-
Drug Approval
-
Humans
-
Immunotherapy
-
Muscles / pathology
-
Nivolumab / therapeutic use
-
Urinary Bladder Neoplasms* / drug therapy
-
Urinary Bladder Neoplasms* / pathology
-
Urinary Bladder Neoplasms* / surgery
Substances
-
Adjuvants, Immunologic
-
B7-H1 Antigen
-
Nivolumab